Subtle Renal Injury Is Likely a Common Mechanism for Salt-Sensitive Essential Hypertension
2005; Lippincott Williams & Wilkins; Volume: 45; Issue: 3 Linguagem: Inglês
10.1161/01.hyp.0000154784.14018.5f
ISSN1524-4563
AutoresRichard J. Johnson, Bernardo Rodríguez‐Iturbe, Takahiko Nakagawa, Duk‐Hee Kang, Daniel I. Feig, Jaime Herrera-Acosta,
Tópico(s)Renal function and acid-base balance
ResumoHomeHypertensionVol. 45, No. 3Subtle Renal Injury Is Likely a Common Mechanism for Salt-Sensitive Essential Hypertension Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBSubtle Renal Injury Is Likely a Common Mechanism for Salt-Sensitive Essential Hypertension Richard J. Johnson, Bernardo Rodriguez-Iturbe, Takahiko Nakagawa, Duk-Hee Kang, Dan I. Feig and Jaime Herrera-Acosta Richard J. JohnsonRichard J. Johnson From the Division of Nephrology, Hypertension, and Transplantation (R.J.J., T.N.), University of Florida, Gainesville; Hospital Universitario and Universidad del Zulia (B.R.-I.), Maracaibo, Venezuela; Division of Nephrology (D.-H.K.), Ewha University College of Medicine, Seoul, Korea; Division of Pediatric Nephrology (D.I.F.), Texas Children's Hospital, Baylor College of Medicine, Houston; and Department of Nephrology (J.H.-A.), Instituto Nacional de Cardiologia I, Mexico City, Mexico. , Bernardo Rodriguez-IturbeBernardo Rodriguez-Iturbe From the Division of Nephrology, Hypertension, and Transplantation (R.J.J., T.N.), University of Florida, Gainesville; Hospital Universitario and Universidad del Zulia (B.R.-I.), Maracaibo, Venezuela; Division of Nephrology (D.-H.K.), Ewha University College of Medicine, Seoul, Korea; Division of Pediatric Nephrology (D.I.F.), Texas Children's Hospital, Baylor College of Medicine, Houston; and Department of Nephrology (J.H.-A.), Instituto Nacional de Cardiologia I, Mexico City, Mexico. , Takahiko NakagawaTakahiko Nakagawa From the Division of Nephrology, Hypertension, and Transplantation (R.J.J., T.N.), University of Florida, Gainesville; Hospital Universitario and Universidad del Zulia (B.R.-I.), Maracaibo, Venezuela; Division of Nephrology (D.-H.K.), Ewha University College of Medicine, Seoul, Korea; Division of Pediatric Nephrology (D.I.F.), Texas Children's Hospital, Baylor College of Medicine, Houston; and Department of Nephrology (J.H.-A.), Instituto Nacional de Cardiologia I, Mexico City, Mexico. , Duk-Hee KangDuk-Hee Kang From the Division of Nephrology, Hypertension, and Transplantation (R.J.J., T.N.), University of Florida, Gainesville; Hospital Universitario and Universidad del Zulia (B.R.-I.), Maracaibo, Venezuela; Division of Nephrology (D.-H.K.), Ewha University College of Medicine, Seoul, Korea; Division of Pediatric Nephrology (D.I.F.), Texas Children's Hospital, Baylor College of Medicine, Houston; and Department of Nephrology (J.H.-A.), Instituto Nacional de Cardiologia I, Mexico City, Mexico. , Dan I. FeigDan I. Feig From the Division of Nephrology, Hypertension, and Transplantation (R.J.J., T.N.), University of Florida, Gainesville; Hospital Universitario and Universidad del Zulia (B.R.-I.), Maracaibo, Venezuela; Division of Nephrology (D.-H.K.), Ewha University College of Medicine, Seoul, Korea; Division of Pediatric Nephrology (D.I.F.), Texas Children's Hospital, Baylor College of Medicine, Houston; and Department of Nephrology (J.H.-A.), Instituto Nacional de Cardiologia I, Mexico City, Mexico. and Jaime Herrera-AcostaJaime Herrera-Acosta From the Division of Nephrology, Hypertension, and Transplantation (R.J.J., T.N.), University of Florida, Gainesville; Hospital Universitario and Universidad del Zulia (B.R.-I.), Maracaibo, Venezuela; Division of Nephrology (D.-H.K.), Ewha University College of Medicine, Seoul, Korea; Division of Pediatric Nephrology (D.I.F.), Texas Children's Hospital, Baylor College of Medicine, Houston; and Department of Nephrology (J.H.-A.), Instituto Nacional de Cardiologia I, Mexico City, Mexico. Originally published17 Jan 2005https://doi.org/10.1161/01.HYP.0000154784.14018.5fHypertension. 2005;45:326–330Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 17, 2005: Previous Version 1 Despite the fact that essential hypertension was originally described as hypertension occurring in the absence of clinical renal disease,1 Dahl et al later showed by transplantation studies in experimental models of hypertension that the kidney is ultimately responsible for the elevation in blood pressure,2 a finding that was verified later in humans.3 Most authorities believe that the mechanism by which the kidney causes hypertension involves a physiological defect in sodium excretion as championed by Guyton et al.4 Support for this mechanism is extensive and includes both epidemiological5 and physiological6 studies.Several hypotheses have been proposed to explain the mechanism responsible for the defect in renal sodium handling. A favored hypothesis is that hypertension results from a polygenic defect in which there are alterations in the regulation or expression in tubular transport systems involved in sodium reabsorption and excretion.7,8 The recent discovery that many forms of genetic hypertension are associated with enhanced sodium reabsorption has provided support for this hypothesis.7,8 However, there are substantial arguments that mitigate this hypothesis as a major mechanism for the renal defect. First, most studies suggest that genetic mechanisms can only account for a minority of cases.9,10 For example, a study of 1003 identical twins found that when one twin was hypertensive, the other twin was hypertensive only 44% of the time.11 Even more convincing are epidemiological data that demonstrate a dramatic increase in the prevalence of hypertension over the last 100 years. Thus, studies in the early 1900s demonstrated a near absence of hypertension in Africa, Asia, Arabia, South America, Australia and New Zealand, and Oceania,12 but now hypertension is rapidly increasing in prevalence, along with the worldwide epidemic of obesity and diabetes.13 Similarly, hypertension was observed in only 10% of the populace in the United States in the early 1930s,14 yet it now affects >30% of the population.15 It is difficult to explain how a purely genetic mechanism could account for this rapid change in prevalence. Finally, a genetic defect in sodium excretion as a primary mechanism for essential hypertension does not easily account for studies that demonstrate that in early hypertension, blood volume and exchangeable sodium tend to be low,16–18 why early hypertension is frequently salt resistant (ie, is not altered by sodium intake),19 and why salt-sensitivity increases progressively with aging.19 Thus, although genetic factors clearly have an important role in the development of salt-sensitive hypertension, there must be other nongenetic mechanisms intricately involved in the pathogenesis.A second favored hypothesis is that essential hypertension results from a congenital reduction in nephron number.20 The argument is based on a series of observations. First, there is evidence for a "maternal factor" in hypertension because hypertension travels more commonly via the mother than the father.21 Indeed, hypertension occurs more commonly if the mother has hypertension, preeclampsia, obesity, or malnutrition.22 In all of these conditions, the mother carries an increased risk for delivering a baby with low birth weight. In turn, low birth weight babies have fewer nephrons because of impaired development of the kidney during the third trimester.23 More importantly, low birth weight babies have an increased risk for hypertension as adults.22 Indeed, low birth weight is especially common among blacks,24 a race that carries the greatest risk for hypertension in the United States. Further support of this hypothesis is the observation that the experimental induction of malnutrition during pregnancy in rats results in pups that are born with low nephron number and later develop salt-sensitive hypertension.25 Autopsy studies of young hypertensive subjects dying from traffic accidents have also verified that the kidneys have significantly fewer nephrons than age-matched normotensive controls.26Whereas the congenital nephron number hypothesis carries great appeal, it also is unlikely to account for the observed alterations in sodium handling. First, numerous studies in renal transplant donors (who have reduced their nephron number in half) have failed to show any substantial increase in hypertension frequency even after 25 years.27 It also is difficult to reconcile the absence of hypertension noted in developing countries in the early 1900s (in which maternal nutrition was likely suboptimal) with the absence of reports of hypertension in those populations.12 It is also difficult to explain the epidemic and worldwide increase in hypertension over the last century13–15 on the basis of maternal malnutrition and a reduction in nephron number. Furthermore, the relationship of birth weight with the later development of hypertension has been difficult to show in some studies28 and when present, is usually subtle (with an ≈2 to 5 mm Hg change in systolic blood pressure noted per kilogram difference in birth weight).29 Perhaps most important is the fact that birth weight can only account for a small percentage of hypertension in the population (Figure).30 Thus, one can demonstrate statistically that low birth weight infants have a higher frequency of hypertension as adults compared with normal or large birth weight babies, but the difference in frequency in one study varied from 28.9% (for low birth weight babies) to 23.8% (for large babies).30 Hence, hypertension was still developing in ≈24% of children even in the absence of a low birth weight. Download figureDownload PowerPointCumulative incidence (%) of hypertension according to the size of birth (in grams) in 1958 men and women born in Helsinki, Finland, between 1924 and 1933. The data are from Table 1 of the original article30 and have been put in bar graph form. Printed with permission from the publisher.The third major hypothesis is that salt-sensitive hypertension results primarily from subtle, acquired renal injury such that renal function is either normal or only minimally depressed and the urinalysis remains normal or shows only microalbuminuria.31 Despite minimal evidence for clinical renal disease, it has been known for >150 years that patients with hypertension almost always have microvascular disease (originally termed arteriocapillary fibrosis and now called arteriolosclerosis) in the systemic and renal vasculature.32 In one study, 98% of kidneys from hypertensive individuals had renal microvascular disease and mild to moderate tubulointerstitial injury.33 Another group reported that it is only when the microvascular disease is in the kidney that there is a correlation with the presence of hypertension.34 Indeed, some studies have demonstrated that the degree of renal microvascular disease correlates closely with the degree of blood pressure elevation.35The observation that renal microvascular disease is present in the majority of subjects with hypertension led Goldblatt to postulate that the microvascular disease was primary and that it caused hypertension via a mechanism involving renal ischemia.36 However, his hypothesis was discarded because he had no mechanism to provide for how the microvascular disease would develop and because it appeared more likely that the microvascular disease was the consequence of hypertensive renal damage. However, recent interest in this pathway was rekindled when it was found that similar types of renal microvascular injury could be induced in animals by a variety of means (including transiently infusing angiotensin II or blocking NO synthesis), and that these animals subsequently develop salt-sensitive hypertension with similar histological, hemodynamic, and functional characteristics as those observed in essential hypertension in man.37 Furthermore, blocking the renal microvascular and interstitial injury with mycophenolate could prevent the cortical vasoconstriction and the development of salt sensitivity.37,38At first, one might postulate that renal afferent arteriolar injury or vasoconstriction should not cause salt sensitivity because Guyton et al provided strong evidence that a rise in preglomerular resistance should shift the pressure natriuresis curve to the right but in parallel, resulting in salt-resistant hypertension.4 Indeed, if the renal vasoconstriction or arteriolar disease is homogeneous (such as occurs when one places a clip to partially occlude a renal artery), then this is true.4 However, because the development of arteriolar disease varies in severity between nephrons, there will be variability in renal perfusion, resulting in some nephrons being underperfused and ischemic, whereas others may be overperfused. This would lead to heterogeneity in renin expression and a functional defect in which the renin-angiotensin system would fail to suppress for the degree of sodium intake, resulting in sodium sensitivity as proposed by Sealey et al.39 Furthermore, we reported that the cortical vasoconstriction with renal ischemia also results in the infiltration of mononuclear cells expressing oxidants and angiotensin II, which also contributes to the sodium retention and a rise in blood pressure.37Recent studies in spontaneously hypertensive rats (SHR) support the importance of the renal afferent arteriole in the pathogenesis of hypertension. Specifically, SHR are known to have a narrow afferent arteriolar lumen and to develop hypertension that has a salt-resistant and salt-sensitive component, in that the hypertension occurs even under low-salt conditions but is also exacerbated with increased sodium intake. Interestingly, SHR also have a reduced nephron number. To sort out which of these characteristics may be responsible for development of hypertension, studies were performed by crossing SHR with Wistar-Kyoto rats, which have a normal nephron number and normal afferent arterioles, and then examining whether hypertension tracked with nephron number or with the arteriolar abnormalities in the offspring. Interestingly, there was no association of hypertension with nephron number,40 whereas a narrowed arteriolar lumen was highly associated with development of hypertension.41 The importance of the arteriolar vasoconstriction42 and of the structural changes41,43 have led others to a similar conclusion that it is arteriolar disease that is critical for development of hypertension.A key question is what causes the renal microvascular and tubulointerstitial injury in essential hypertension. A possibility is that the renal microvascular injury may be initiated by transient rises in blood pressure induced by a hyperactive sympathetic nervous system (SNS).31 It is known, for example, that subjects at risk for developing hypertension frequently give a history of work stress, have type A personalities, or show enhanced cold pressor responses.31 White coat or episodic hypertension is also recognized as a major risk factor for development of hypertension,44,45 and ≈40% of early hypertension is associated with a hyperactive SNS and intermittent elevations in blood pressure.46 Indeed, infusion of catecholamines into rats also will induce renal microvascular and interstitial injury with the development of salt sensitivity that persists after stopping the catecholamine.47Another risk factor for hypertension is an elevated serum uric acid.48 An elevated serum uric acid not only predicts but is present in as many as 90% of new-onset primary hypertension in adolescents.48 Epidemiologically, the rise in the worldwide prevalence of hypertension and obesity correlates with a rise in the mean serum uric acid in the population.12 Experimental hyperuricemia in rats also results in hypertension and renal microvascular disease.49 Interestingly, the initial hypertension in hyperuricemic rats is mediated by systemic endothelial dysfunction and activation of the renin-angiotensin system and is salt resistant.50–52 However, over time, uric acid mediates renal microvascular disease, in part by a direct effect of uric acid on vascular smooth muscle cell (VSMC) proliferation.52 Once the renal microvascular disease is substantial, the hypertension "switches" to a salt-sensitive form and is now independent of uric acid levels and driven by the kidney.52 In this case, lowering uric acid may be most effective as a preventative measure or in early forms of hypertension; indeed, preliminary studies suggest lowering uric acid may be effective at treating blood pressure in hypertensive adolescents.53A hyperactive SNS and hyperuricemia are thus likely initiators of renal microvascular injury and development of salt sensitivity. Interestingly, both would take the patient through an initial renal independent, salt-resistant mechanism, followed by development of renal microvascular injury and a volume-dependent, salt-sensitive pathway. This switch is likely the result of VSMC proliferation leading to a permanent state of decreased afferent flow equivalent to the vasoconstriction mediated by hyperuricemia. This is consistent with temporal studies in humans suggesting that hypertension in younger subjects is more frequently associated with salt resistance, low volume, high uric acid, and a hyperactive SNS, whereas hypertension in older subjects is more commonly associated with salt sensitivity, a reduced glomerular filtration rate, microalbuminuria, and more severe renal microvascular disease.16–19 These data are consistent with reports linking uric acid and a hyperactive SNS with elevated plasma renin activity,46,54 and with the proposal by Blumenfeld and Laragh that hypertension can be categorized primarily as either renin dependent or volume dependent.55Other mechanisms are also likely operative. Animal models indicate that the pathway can be engaged by angiotensin II, lead, cyclosporine, aging, chronic low-potassium diets, and even chronic hypoxia.37 There is accruing evidence that lead intoxication can induce renal arteriolar lesions and hypertension;56 lead can also raise serum uric acid.57 SHR suggest genetic mechanisms that may govern renal afferent arteriolar tone and structure. This potential plurality of triggers, working independently or in concert, is likely at the crux of the decades-long challenge of truly understanding essential hypertension.In conclusion, acquired renal microvascular and tubulointerstitial injury becomes the most likely mechanism to account for the development of salt-sensitive hypertension. Uric acid,48 endothelial dysfunction,58 or a hyperactive SNS46 are likely key initiators of this process. Clearly, genetic and congenital mechanisms are contributory, but they are unlikely to account for the majority of hypertension. Interestingly, an elevated uric acid in the mother may also have a role in mediating a reduction in nephron number,53 and a reduced nephron number may predispose to development of preglomerular renal microvascular disease.59 Thus, the genetic and congenital nephron hypotheses are likely contributing cofactors involved in the hypertensive response. Finally, although this article reviews mechanisms that may result in the defect in sodium excretion as elegantly hypothesized by Guyton, we do not discuss how the renal defect leads to systemic vasoconstriction and development of hypertension. However, it is likely that transient retention of sodium results in the release of factors from the hypothalamus and adrenal, such as cardiotonic steroids, that may activate the Na+/Ca2+ exchanger in VSMCs to cause systemic vascular vasoconstriction and a rise in blood pressure,60 as postulated by Blaustein61 and DeWardener,62 resulting in "autoregulation," as originally proposed by Guyton et al.4We have come a long way since the original debate 150 years ago between George "Kidney" Johnson63 and Gull and Sutton32 over whether hypertension is attributable to the kidney or to arteriolosclerosis. The verdict may soon be in. Both are likely right.AcknowledgmentsThis work was supported by National Institutes of Health grants DK-52121 and HL68607 and a George O'Brien Kidney Center grant (DK-64233).FootnotesCorrespondence to Richard J. Johnson, MD, Division of Nephrology, Hypertension, and Transplantation, University of Florida, P.O. Box 100224, Gainesville, FL 32610. [email protected]References1 Mahomed FA. On chronic Bright's disease and its essential symptoms. Lancet. 1879; i: 399–401.Google Scholar2 Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res. 1975; 36: 692–696.CrossrefMedlineGoogle Scholar3 Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethelm AG. Remission of essential hypertension after renal transplantation. N Engl J Med. 1983; 309: 1009–1015.CrossrefMedlineGoogle Scholar4 Guyton AC, Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972; 52: 584–594.CrossrefMedlineGoogle Scholar5 Elliott P, Stamler J, Nichols R, Dyer AR, Stamnler R, Kesteloot H, Marmot M; Intersalt Cooperative Research Group. Intersalt revisited: further analysis of 24 hour sodium excretion and blood pressure within and across populations. BMJ. 1996; 312: 1249–1253.CrossrefMedlineGoogle Scholar6 MacGregor GA, Markandu ND, Best FE, Elder DM, Cam JM, Sagnella GA, Squires M. Double-blind randomized crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982; 1: 351–355.CrossrefMedlineGoogle Scholar7 Lifton RP. Molecular genetics of human blood pressure variation. Science. 1996; 272: 676–680.CrossrefMedlineGoogle Scholar8 Karet FE, Lifton RP. Mutations contributing to human blood pressure variation. Recent Prog Horm Res. 1997; 52: 263–277.MedlineGoogle Scholar9 Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, Benjamin N, Webster J, Ratcliffe P, O'Shea S, Papp J, Taylor E, Dobson R, Knight J, Newhouse S, Hooper J, Lee W, Brain N, Clayton D, Lathrop GM, Farrall M, Connell J. Genome-wide mapping of human loci for essential hypertension. Lancet. 2003; 361: 2118–2123.CrossrefMedlineGoogle Scholar10 Province MA, Kardia SL, Ranade K, Rao DC, Thiel BA, Cooper RS, Risch N, Turner ST, Cox DR, Hunt SC, Weder AB, Boerwinkle E. A meta-analysis of genome-wide linkage scans for hypertension: the National Heart, Lung and Blood Institute Family Blood Pressure Program. Am J Hypertens. 2003; 16: 144–147.CrossrefMedlineGoogle Scholar11 Carmelli D, Robinette D, Fabsitz R. Concordance, discordance and prevalence of hypertension in World War II male veteran twins. J Hypertens. 1994; 12: 323–328.MedlineGoogle Scholar12 Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution, and primitive cultures. Semin Nephrol. 2005; 25: 3–8.CrossrefMedlineGoogle Scholar13 Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001; 104: 2746–2753.CrossrefMedlineGoogle Scholar14 Robinson SC, Brucer M. Range of normal blood pressure. A statistical and clinical study of 11 383 persons. Arch Int Med. 1939; 64: 409–444.CrossrefGoogle Scholar15 Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000. A rising tide. Hypertension. 2004; 44: 398–404.LinkGoogle Scholar16 Lebel M, Grose JH, Blais R. Abnormal relation of extracellular fluid volume and exchangeable sodium with systemic arterial pressure in early borderline essential hypertension. Am J Cardiol. 1984; 54: 1267–1271.CrossrefMedlineGoogle Scholar17 Beretta-Piccoli C, Davies DL, Boddy K, Brown JJ, Cumming AMM, East BW, Fraser R, Lever AF, Padfield PL, Semple PF, Roberston JIS, Weidmann P, Williams ED. Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci. 1982; 63: 257–270.CrossrefMedlineGoogle Scholar18 Beretta-Piccoli C, Weidman P. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines. Miner Electrolyte Metab. 1984; 10: 292–300.MedlineGoogle Scholar19 Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension. 1991; 18: 67–71.LinkGoogle Scholar20 Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens. 1988; 1: 335–347.CrossrefMedlineGoogle Scholar21 Murakami K, Kojima S, Kimura G, Sanai T, Yoshida K, Imanishi M, Abe H, Kawamura M, Kawano Y, Ashida T. The association between salt sensitivity of blood pressure and family history of hypertension. Clin Exp Pharmacol Physiol Suppl. 1992; 20: 61–63.MedlineGoogle Scholar22 Barker DJ. The fetal origins of adult hypertension. J Hypertens Suppl. 1992; 10: S39–S44.CrossrefMedlineGoogle Scholar23 Hughson M, Farris AB, Douglas-Denton R, Hoy WE, Bertram JF. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003; 63: 2113–2122.CrossrefMedlineGoogle Scholar24 Ventura SJ, Anderson RN, Martin JA, Smith BL. Births and deaths; preliminary data for 1997. Natl Vital Stat Rep. 1998; 47: 1–41.Google Scholar25 Woods LL, Weeks DA, Rasch R. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int. 2004; 65: 1339–1348.CrossrefMedlineGoogle Scholar26 Keller J, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003; 348: 101–118.CrossrefMedlineGoogle Scholar27 Goldfarb DA, Matin SF, Braun WE, Schreiber MJ, Mastroianni B, Papajcik D, Rolin HA, Flechner S, Goormastic M, Novick AC. Renal outcome 25 years after donor nephrectomy. J Urol. 2001; 166: 2043–2047.CrossrefMedlineGoogle Scholar28 Falkner B, Hulman S, Kushner H. Effect of birth weight on blood pressure and body size in early adolescence. Hypertension. 2004; 43: 203–207.LinkGoogle Scholar29 Law CM, Shiell AW. Is blood pressure inversely related to birth weight? The strength of the evidence from a systematic review of the literature. J Hypertens. 1996; 14: 936–941.Google Scholar30 Eriksson J, Forsén T, Tuomilehto J, Osmod C, Barker D. Fetal and childhood growth and hypertension in adult life. Hypertension. 2000; 36: 790–794.CrossrefMedlineGoogle Scholar31 Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002; 346: 913–923.CrossrefMedlineGoogle Scholar32 Gull W, Sutton H. On the pathology of the morbid state commonly called chronic Bright's disease with contracted kidney ("arteriocapillary fibrosis"). Med Chir Trans. 1872; 55: 325–371.Google Scholar33 Sommers S, Relman R, Smithwick R. Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol. 1958; 34: 685–715.MedlineGoogle Scholar34 Moritz A, Oldt M. Arteriolar sclerosis in hypertensive and nonhypertensive individuals. Am J Pathol. 1937; 13: 679–728.MedlineGoogle Scholar35 Tracy RE, Mercante DE, Moncada A, Berenson G. Quantitation of hypertensive nephrosclerosis on an objective rational scale of measure in adults and children. Am J Clin Pathol. 1986; 85: 312–318.CrossrefMedlineGoogle Scholar36 Goldblatt H. The renal origin of hypertension. Physiol Rev. 1947; 27: 120–165.CrossrefMedlineGoogle Scholar37 Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J. A unifying pathway for essential hypertension. Am J Hypertens. In press.Google Scholar38 Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol. 2004; 286: F606–F616.CrossrefMedlineGoogle Scholar39 Sealey JE, Blumenfeld JD, Bell GM, Pecker MS, Sommers SC, Laragh JH. On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. J Hypertens. 1988; 6: 763–777.CrossrefMedlineGoogle Scholar40 Black MJ, Briscoe TA, Constantinou M, Kett MM, Bertram JF. Is there an association between level of adult blood pressure and nephron number or surface area? Kidney Int. 2004; 65: 582–588.CrossrefMedlineGoogle Scholar41 Skov K, Mulvany MJ. Structure of renal afferent arterioles in the pathogenesis of hypertension. Acta Physiol Scand. 2004; 181: 397–405.CrossrefMedlineGoogle Scholar42 Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand. 2003; 179: 217–223.CrossrefMedlineGoogle Scholar43 Anderson WP, Kett MM, Stevenson KM, Edgley AJ, Denton KM, Fitzgerald SM. Renovascular hypertension: structural changes in the renal vasculature. Hypertension. 2000; 36: 648–652.CrossrefMedlineGoogle Scholar44 Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber M, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens. 1996; 14: 327–332.CrossrefMedlineGoogle Scholar45 Levy R, Hillman C, Stroud W, White P. Transient hypertension: It significance in terms of later development of sustained hypertension and cardiovascular renal disease. J Am Med Assoc. 1944; 126: 829–833.CrossrefGoogle Scholar46 Julius S. The evidence for a pathophysiologic significance of sympathetic overactivity in hypertension. Clin Exp Hypertens. 1996; 18: 305–321.CrossrefMedlineGoogle Scholar47 Johnson RJ, Gordon KL, Suga S, Griffin K, Bidani A. Renal injury and salt-sensitive hypertension after exp
Referência(s)